Skip to main content
2022 Guide to Patient Support Services

TG Therapeutics

2022 Oncology Guide to Patient Support Services

TG Therapeutics Patient Support Services

877-848-9777

TG Therapeutics offers the TG Patient Support program to assist patients while taking Ukoniq (Table).

TG Patient Support

In addition to insurance support, this program offers financial assistance programs for your patients through the TG Commercial Co-pay Program, Quick Start and Bridge Programs, and Patient Assistance Program, as well as educational support through TG Patient Support Dedicated Care Team.

TG Commercial Co-pay Program

Patients with commercial or private insurance may be eligible to receive Ukoniq for as little as $5 per prescription with a $25,000 annual cap. Patients may be eligible if they:

  • Are at least 18 years of age
  • Have commercial prescription drug coverage
  • Do not participate in federal or state government prescription drug programs, including Medicare, Medicaid, TRICARE, Veterans Affairs, Department of Defense, or the Government Health Insurance Plan available in Puerto Rico.

Click here to enroll your patient in the TG Commercial Co-pay Program.

Quick Start and Bridge Programs

Patients with a 5-day delay or lapse in insurance coverage may be eligible to receive a 15-day supply of Ukoniq to prevent prolonged delays or interruptions in therapy. You can request Quick Start or Bridge support for your patient on the TG Patient Support enrollment form.

Patient Assistance Program

For eligible patients who are uninsured or underinsured, the Patient Assistance Program may be able to provide Ukoniq at no cost. Patients may be eligible if they:

  • Have no insurance
  • Are underinsured
  • Have an annual family gross income equal to or less than 600% of the current federal poverty level.

TG Patient Support Dedicated Care Team

Patients enrolled in the TG Patient Support program have access to case managers who will provide reimbursement support and facilitate financial assistance for eligible patients and registered nurses who help patients prepare for treatment with Ukoniq.

Click here to learn more or to enroll your patient in the TG Patient Support program, or call 877-848-9777.

TABLE TG Therapeutics Oncology Drug

Drug
Indications
Patient support programs

Drug
Ukoniq (umbralisib)
Indications
Treatment of adults with relapsed or refractory marginal zone lymphoma who have received at least 1 prior anti-CD20–based regimen; treatment of adults with relapsed or refractory follicular lymphoma who have received at least 3 prior lines of systemic therapy
Patient support programs

Report Broken Links

Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?

Help us fix it! Report broken links here.

Report Broken Links

Report Broken Links

*OPM Webpage
Please copy the URL (link) of the OPM webpage you are currently on.
*Broken Link
Please copy the URL (link) to the external webpage that is not displaying content correctly.
Errors include, but are not limited to:
  • "This site can’t be reached"
  • "Hmm. We’re having trouble finding that site."
  • "Hmmm… can't reach this page"
  • "404 Error: Page not found"
Comments
(Optional)